Clinical Trials Browser

Phase 1/2 × Unknown × Locally Advanced or Metastatic Gastric Adenocarcinoma × Clear all

NCT04572542 2020-10-01

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

Phase 1/2 Unknown

Gastrointestinal

Locally Advanced or Metastatic Gastric Adenocarcinoma